Nancy Denyes, General Counsel at aTYR PHARMA INC (LIFE), sold 322 shares at $3.62 ($1K) on 2020-05-20, disclosed to the SEC on 2020-05-28.
Scheduled sale ($1k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ATYR | BUY | 2024-06-06 | $9K | — | Filing → |